Carcinom of the paranasal sinuses--a review of 158 cases.
One hundred and fifty-eight cases of paranasal sinus cancer have been reviewed retrospectively. The actuarial survival at five years for the whole group was 33%. The American Joint Committee (AJC) classification for maxillary cancer was used. T1 and T2 cases, with an actuarial survival of 44% at five years, had a significantly better prognosis than T3 cases (31%) and T4 cases (10%). Anemia of presentation and the presence of persistent disease when surgery followed pre-operative irradiation were poor prognostic indicators. The policy of combined pre-operative irradiation followed by surgery is advocated; patients with anemia should have this corrected before and during treatment.
D000328:Adult; D000368:Aged; D002386:Cataract / Q000209:etiology; D003037:Cobalt Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D005005:Ethmoid Sinus; D005260:Female; D005626:Frontal Sinus; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008443:Maxillary Sinus; D008875:Middle Aged; D010255:Paranasal Sinus Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011183:Postoperative Complications; D011379:Prognosis; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D012189:Retrospective Studies; D013101:Sphenoid Sinus
D003037:Cobalt Radioisotopes